(Q45051446)

8 December 2017

title

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer (English)

1 reference

8 December 2017

main subject

phase I clinical trial

0 references

1 reference

Kalemkerian GP

1

1 reference

8 December 2017

Belzer K

2

1 reference

8 December 2017

Wozniak AJ

3

1 reference

8 December 2017

Gaspar LE

4

1 reference

8 December 2017

Valdivieso M

5

1 reference

8 December 2017

Kraut MJ

6

1 reference

8 December 2017

publication date

1 September 1999

1 reference

8 December 2017

1 reference

8 December 2017

volume

25

1 reference

8 December 2017

issue

3

1 reference

8 December 2017

page(s)

175-182

1 reference

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Treatment of cancer with radiation and drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Clinical radiosensitization: why it does and does not work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Feasibility of escalating daily doses of cisplatin in combination with accelerated radiotherapy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

cis-Diamminedichloroplatinum(II) given in low-dose continuous infusion with concurrent radiotherapy to patients affected by inoperable lung carcinoma: a pharmacokinetic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

Hyperfractionated radiotherapy and concomitant cisplatin in stage III non-small cell lung cancer: a phase II study by the AIRO-Lombardia Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

A pilot study of protracted low dose cisplatin and etoposide with concurrent thoracic radiotherapy in unresectable stage III nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900060-4

7 January 2021

10.1016/S0169-5002(99)00060-4

Identifiers

DOI

1 reference

8 December 2017

1 reference